Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Getinge AB

Market Cap 53.45B 5.69B 4.91B 4.53B 4.24B 7.94B 541B 8.06B 20.84B 263B 21.35B 20.89B 911B P/E Ratio 2026 *
18.9x
P/E Ratio 2027 * 16.1x
Enterprise Value 61.86B 6.58B 5.69B 5.24B 4.9B 9.19B 626B 9.33B 24.12B 305B 24.71B 24.18B 1,055B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.63x
Free-Float
78.61%
Yield 2026 *
2.57%
Yield 2027 * 2.79%
1 day-13.69%
3 months-13.69%
6 months-4.52%
Current year-9.28%
Current year 20.05
Extreme 20.05
24.75
1 year 18.82
Extreme 18.82
24.75
3 years 15.62
Extreme 15.62
24.75
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO - 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-13.69%-.--% - - 5.69B
+0.12%-0.57%+24.25%-3.92% 12.54B
-4.84%-3.63%+55.38%+31.42% 6.02B
+2.67%+1.72%-29.06%+20.38% 4.28B
-2.00%+6.54% - - 4.26B
+2.53%+0.15%-27.61%-22.23% 3.83B
+0.40%+3.61%+1.31%-60.88% 2.06B
+5.23%+3.92%+42.89%+192.67% 1.76B
-2.11%-1.15%+58.43%-4.74% 1.56B
+2.24%-7.42%-12.44%-49.53% 1.31B
Average -0.94%+0.69%+14.15%+12.90% 4.18B
Weighted average by Cap. -1.92%+0.53%+16.81%+8.49%

Financials

2026 *2027 *
Net sales 34.91B 3.71B 3.21B 2.96B 2.77B 5.19B 353B 5.27B 13.61B 172B 13.94B 13.64B 595B 36.63B 3.9B 3.37B 3.1B 2.9B 5.44B 370B 5.53B 14.28B 180B 14.63B 14.32B 624B
Net income 2.81B 299M 258M 238M 223M 417M 28.42B 424M 1.1B 13.83B 1.12B 1.1B 47.9B 3.31B 352M 304M 281M 263M 492M 33.5B 500M 1.29B 16.31B 1.32B 1.29B 56.47B
Net Debt 8.41B 895M 773M 712M 667M 1.25B 85.08B 1.27B 3.28B 41.41B 3.36B 3.29B 143B 6.32B 673M 581M 535M 501M 939M 63.93B 954M 2.46B 31.12B 2.52B 2.47B 108B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,754
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
196.25SEK
Average target price
227.20SEK
Spread / Average Target
+15.77%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!